First Boron MRI of a Human Patient with a Brain Tumor
Major challenges in the successful administration of BNCT include the development of the BNCT compound used to deliver 10B preferentially to the tumor cells and the analysis of the compound. To obtain treatment parameters this analysis must accurately reveal the distribution and concentration of the boron compound. This analysis can either be invasive or noninvasive. However, with invasive analysis we take the risk of disturbing the biological environment to the extent that the data will be biased. When performing invasive pharmacokinetic studies of a boron compound candidate, we also have the disadvantage that data sampling is often limited to one sample per animal or human experiment requiring multiple experiments per time point in order to have a statistically meaningful data set. We have introduced a method in which patient treatment parameters may be determined noninvasively. Furthermore, nonivasive data acquisition per experiment can be maximized for potential boron compound pharmacokinetic studies.
KeywordsInductively Couple Plasma Atomic Emission Spectroscopy Glioblastoma Multiforme Inductively Couple Plasma Atomic Emission Spectroscopy Magnetic Resonance Imaging System Boron Compound
Unable to display preview. Download preview PDF.
- 2.S.P. Hendee, K.M. Bradshaw, J.R. Hadley, P.-P.Z. Tang, and M.P. Schweizer. In vivo NMR evaluation of the pharmacokinetics of boronated compounds in the rat model, in: “Cancer Neutron Capture Therapy,” Mishima, Y., ed. Plenum Press, New York, 1995, (in this volume).Google Scholar
- 3.M.P. Schweizer, K.M. Bradshaw, J.R. Hadley, et al. Boron MRI in a tumor bearing canine model, in: “Cancer Neutron Capture Therapy,” Mishima, Y., ed. Plenum Press, New York, 1995, (in this volume).Google Scholar
- 4.C.E. Hayes, W.A. Edelstein, J.F. Schenck, O.M. Mueller, and M. Eash, An efficient, highly homogeneous radiofrequency coil for whole-body NMR imaging at 1.5T, J. Magn. Reson. 63: 622–628, 1985.Google Scholar
- 5.C.E. Hayes, An endcap birdcage resonator for quadrature head imaging, in “Works in Prog., SMRM, 5th Annual Meeting, 1986,” p. 39–40.Google Scholar
- 6.K.M. Bradshaw, M.P. Schweizer, G.H. Glover, and J.R. Hadley. Pharmacokinetics of borocaptate sodium in canine head determined by boron-11 magnetic resonance imaging and spectroscopy, in: “Advances in Neutron Capture Therapy,” Soloway, A.H., Barth, R.F., and Carpenter, D.E., eds., Plenum Press, New York, 1993, pp. 579–583CrossRefGoogle Scholar
- 8.K.M. Bradshaw, G.H. Glover, J.R. Hadley, and M.P. Schweizer, Use of ‘‘B 3d projection reconstruction to determine in vitro boron concentration when bound to albumin, in “Proc., SMRM, 12“ Annual Meeting, 1993,” p. 889.Google Scholar